Abstract
Novel treatments for substance use disorders (SUDs) include rapid‐acting psychotherapeutics, in particular, psychedelics, and a “Perspective” published in Neuropsychopharmacology June 22, that was written by the heads of federal research agencies calls for evaluating these approaches.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have